UPCOMING SESSIONS in ET
Wed, Apr 1, 2026
10:00 – 11:00 PM UTC
Facing Fear & Pain in Amyloidosis: How to Take Back Control and Shorten the Storm Cath Jayasuriya Click To Register
UPCOMING SESSIONS in ET
Wed, Apr 1, 2026 · 10:00 – 11:00 PM UTC
Facing Fear & Pain in Amyloidosis: How to Take Back Control and Shorten the Storm
Cath Jayasuriya
Click To Register
View all sessions
Jan 20, 2026
If you have transthyretin cardiac amyloidosis (ATTR-CM)external link, opens in a new tab, the same misshapen proteins that affect your heart can also build up…
Jan 16, 2026
AbstractBackgroundHeart failure is a clinical syndrome resulting from numerous pathological conditions. One cause of heart failure, transthyretin cardiac…
Jan 13, 2026
AbstractBackgroundTransthyretin amyloid cardiomyopathy (ATTR-CM) is an increasingly recognized but still underdiagnosed cause of heart failure in older people,…
Jan 08, 2026
BackgroundSystemic light-chain (AL) amyloidosis is a rare plasma cell disorder with an annual incidence of approximately 8–12 cases per million population in…
Jan 05, 2026
AbstractWild-type transthyretin amyloidosis is a disease characterized by deposition of transthyretin amyloid protein in systemic organs and tissues, especially the…
Jan 02, 2026
Living with amyloidosis can mean a wide variety of symptoms, ranging from heart issues to carpal tunnel. We know that amyloidosis comes with many possible…
Jan 02, 2026
AbstractAmyloid transthyretin (ATTR) amyloidosis is a fatal disease caused by the accumulation of misfolded transthyretin proteins. Although knocking down the TTR…
Jan 02, 2026
If you’ve been diagnosed with amyloidosis, your doctor will assess how far the disease has progressed. This is called staging. As you go through amyloidosis…
Jan 02, 2026
Transthyretin amyloid cardiomyopathy (ATTR-CM) is a type of amyloidosis that affects the heart. It happens when a protein called transthyretin builds up in the…
Dec 26, 2025
AbstractAimsTransthyretin amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed cause of heart failure. With a male:female ratio of approximately 10:1, current…